 | Info
Sheets |
| | | | | | | | | | | | | | | | | | | | | | | | |
 | Out-
side |
| | | | |
|
| | | | |
Result : Searchterm 'DWI' found in 1 term [ ] and 40 definitions [ ]
| | previous 16 - 20 (of 41) nextResult Pages : [1] [2 3 4 5 6 7 8 9] |  | |  | Searchterm 'DWI' was also found in the following services: | | | | |
| |  |
| |
|
(WFS) The water fat shift defines the frequency bandwidth resulting in pixel shift due to the water/fat spectral separation. WFS decreases or increases to a specified number of pixels in mm. The amount of WFS is proportional to the main magnetic field.
See Bandwidth. | | | | | | | | | | | | |  Further Reading: | Basics:
|
|
| |
| | | | | |
| |
|
From Hitachi Medical Systems America Inc.;
the AIRIS II, an entry in the diagnostic category of open MR systems, was designed by Hitachi
Medical Systems America Inc. (Twinsburg, OH, USA) and Hitachi Medical Corp. (Tokyo) and is manufactured by the Tokyo branch. A 0.3 T field-strength magnet and phased array coils deliver high image quality without the need for a tunnel-type high-field system, thereby significantly improving patient comfort not only for claustrophobic patients.
Device Information and Specification
CLINICAL APPLICATION
Whole body
QD Head, MA Head and Neck, QD C-Spine, MA or QD Shoulder, MA CTL Spine, QD Knee, Neck, QD TMJ, QD Breast, QD Flex Body (4 sizes), Small and Large Extrem., QD Wrist, MA Foot and Ankle (WIP), PVA (WIP)
SE, GE, GR, IR, FIR, STIR, FSE, ss-FSE, FLAIR, EPI - DWI, SE-EPI, ms - EPI, SSP, MTC, SARGE, RSSG, TRSG, MRCP, Angiography: CE, 2D/3D TOF
IMAGING MODES
Single, multislice, volume study
TR
SE: 30 - 10,000msec GE: 20 - 10,000msec IR: 50 - 16,700msec FSE: 200 - 16,7000msec
TE
SE : 10 - 250msec IR: 10 -250msec GE: 5 - 50 msec FSE: 15 - 2,000
0.05 sec/image (256 x 256)
2D: 2 - 100 mm; 3D: 0.5 - 5 mm
Level Range: -2,000 to +4,000
POWER REQUIREMENTS
208/220/240 V, single phase
COOLING SYSTEM TYPE
Air-cooled
2.0 m lateral, 2.5 m vert./long
| | | |
• View the DATABASE results for 'AIRIS II™' (2).
| | | | |
| | | | | |
| |
|
From Hitachi Medical Systems America, Inc.;
the AIRIS made its debut in 1995. Hitachi followed up with the AIRIS II system, which has proven equally successfully. 'All told, Hitachi has installed more than 1,000 MRI systems in the U.S., holding more than 17 percent of the total U.S. MRI installed base, and more than half of the installed base of open MR systems,' says Antonio Garcia, Frost and Sullivan industry research analyst.
Now Altaire employs a blend of innovative Hitachi features called VOSIâ„¢ technology, optimizing each sub-system's performance in concert with the
other sub-systems, to give the seamless mix of high-field performance
and the patient comfort, especially for claustrophobic patients, of open MR systems.
Device Information and Specification
CLINICAL APPLICATION
Whole body
DualQuad T/R Body Coil, MA Head, MA C-Spine, MA Shoulder, MA Wrist, MA CTL Spine, MA Knee, MA TMJ, MA Flex Body (3 sizes), Neck, small and large Extremity, PVA (WIP), Breast (WIP), Neurovascular (WIP), Cardiac (WIP) and MA Foot//Ankle (WIP)
SE, GE, GR, IR, FIR, STIR, ss-FSE, FSE, DE-FSE/FIR, FLAIR, ss/ms-EPI, ss/ms EPI- DWI, SSP, MTC, SE/GE-EPI, MRCP, SARGE, RSSG, TRSG, BASG, Angiography: CE, PC, 2D/3D TOF
IMAGING MODES
Single, multislice, volume study
TR
SE: 30 - 10,000msec GE: 3.6 - 10,000msec IR: 50 - 16,700msec FSE: 200 - 16,7000msec
TE
SE : 8 - 250msec IR: 5.2 -7,680msec GE: 1.8 - 2,000 msec FSE: 5.2 - 7,680
0.05 sec/image (256 x 256)
2D: 2 - 100 mm; 3D: 0.5 - 5 mm
Level Range: -2,000 to +4,000
COOLING SYSTEM TYPE
Water-cooled
3.1 m lateral, 3.6 m vertical
| | | |
• View the DATABASE results for 'Altaire™' (2).
| | | | | | Further Reading: | News & More:
|
|
| |
| | | Searchterm 'DWI' was also found in the following services: | | | | |
| | | | | | | |
| |
|
The company is a member of the Bracco Group, a highly innovative healthcare group and world leader in global integrated solutions for the diagnostic medical imaging field. The Bracco Group is headquartered in Milan, Italy. Its North American operations consist of Bracco Diagnostics and Bracco Research USA, both located in Princeton, New Jersey. Bracco Diagnostics is one of the fastest growing developers and marketers of diagnostic pharmaceuticals in North America, with products for various imaging applications, including Isovue® (iopamidol - X-ray contrast agent), ProHance® ( gadoteridol - MRI contrast agent), SonoVue® ( ultrasound contrast agent) and nuclear medicine products.
Gadoteridol has been available in Europe and the USA for several years.
Holder of the Marketing Authorization:
Bracco International B.V. - Strawinskylaan 3051 - 1077 ZX Amsterdam
The Netherlands. (Contact: Kirk Deeter, Phone: +NL-303-838-8708)
MRI Contrast Agents:
Contact Information
Please see Bracco Diagnostics, Inc.'s
| | | |
• View the DATABASE results for 'Bracco Diagnostics, Inc.' (2).
| | | | | | Further Reading: | News & More:
|
|
| |
| | | | |
| | |
| | | |
|
| |
 | Look
Ups |
| |
(.pdf)
Random Page
top
